FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients… Read More »
“Doctors undergo mandatory training sessions in medical school to prepare for unexpected medical emergencies. Health care workers are mandated reporters who have to undergo specific training for the purpose of identifying child and elder abuse or neglect. Bystander intervention should also be on that continuum of responsibility and training. I urge bystander intervention training to… Read More »
Dive Brief: DaVita, which operates outpatient care center centers across the U.S. focusing on kidney care and dialysis, along with its former CEO Kent Thiry, received a two-count federal indictment from a grand jury for conspiring with competing companies to not poach each other’s senior-level employees. The indictment alleges the company and its CEO engaged… Read More »
Dr. Nahid Bhadelia, founding director of the Center for Emerging Infectious Diseases at Boston University, told CNBC, that, medically, she agrees with President Joe Biden‘s assertion that platforms like Facebook are killing people by allowing Covid-19 vaccine misinformation on their services. “I think social media is playing a big role in amplifying misinformation, which is leading… Read More »